0001209191-17-049764.txt : 20170821 0001209191-17-049764.hdr.sgml : 20170821 20170821212116 ACCESSION NUMBER: 0001209191-17-049764 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170817 FILED AS OF DATE: 20170821 DATE AS OF CHANGE: 20170821 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KINGSLEY ALFRED D CENTRAL INDEX KEY: 0001229339 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 171044047 MAIL ADDRESS: STREET 1: 150 E 57TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 1010 ATLANTIC AVENUE STREET 2: SUITE 102 CITY: ALAMEDA STATE: CA ZIP: 94501 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-08-17 0 0000876343 BIOTIME INC BTX 0001229339 KINGSLEY ALFRED D 150 E. 57TH STREET NEW YORK NY 10022 1 1 0 0 See Remarks Common Shares, no par value 2017-08-17 4 D 0 300000 2.81 D 5481555 D Common Shares, no par value 1143346 I By Greenbelt Corp. Common Shares, no par value 375351 I By Greenway Partners, LP On August 17, 2017, Mr. Kingsley exchanged 300,000 BioTime common shares for 421,500 common shares of AgeX Therapeutics, Inc., a subsidiary of BioTime. Does not include shares that Mr. Kingsley may acquire through the exercise of certain options. Mr. Kingsley is Chairman of certain BioTime subsidiaries. /s/Alfred D. Kingsley 2017-08-21